Generic Medicine Presentation Vaccines 
pharmaphorum
MARCH 29, 2022
With the rapid onset of the pandemic, the race to develop a viable vaccine quickly became a race to secure access to the developed vaccines. In this article, Ben Hargreaves examines how wealth determined the winners and what is now underway to help lower-income countries gain access to the available vaccines.
Express Pharma
APRIL 16, 2024
As the world’s leading supplier of generic drugs, India’s pharmaceutical industry has become a ray of hope for millions as it ensures quality-assured and cost-effective treatments reach those who need them the most. It also contributes to 40 per cent of medications in the US and 33 per cent in the EU.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
MAY 10, 2024
As the world’s leading supplier of generic drugs, India’s pharmaceutical industry has become a ray of hope for millions as it ensures quality-assured and cost-effective treatments reach those who need them the most. The country accounts for 20 per cent of the world’s generic drugs and 60 per cent of the global vaccine supply.
Express Pharma
JUNE 15, 2024
India, synonymous with the “pharmacy of the world” has rightfully earned the title, owing to its remarkable contribution in supplying 20 per cent of the global generic medicines, along with 60 per cent of the total vaccine demand worldwide. For this, a two-pronged approach is necessary.
Express Pharma
NOVEMBER 1, 2024
Over 70 per cent of these conditions lack a cure and often go unnoticed, presenting a significant opportunity for drug repurposing in India. The high cost and lengthy development process of new drugs, particularly for rare diseases, present significant challenges.
pharmaphorum
MAY 27, 2022
Once stakeholders are confident that technologies are adequately validated, selection based on scientific and ethical considerations can be presented to regulators in accordance with applicable legal and regulatory frameworks. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.
Express Pharma
JULY 3, 2023
There is no doubt that cell and gene therapies present some of the most exciting opportunities for emerging drugs. Many millions of people are vaccinated against COVID-19, thanks to a messenger RNA (mRNA) encapsulated within a lipid nanoparticle. What are the growth opportunities opening up in the pharma sector, globally and in India?
Expert insights. Personalized for you.
95 
Let's personalize your content